Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.

Authors
Category Primary study
JournalActa physiologica Hungarica
Year 1992
The authors report their experience in the use of ursodeoxycholic acid and silymarin in patients with active cirrhosis of different aetiology. Both drugs seemed safe and ameliorated the biochemical indices of cytolysis; however, the former did not appear to be effective when hepatic dysfunction was associated to hepatitis C infection. The residual functional liver mass, as assessed by quantitative liver function tests, was not affected by either cytoprotective agent.
Epistemonikos ID: 33bbda044861702b24f88b1f07f7e84eb176b31b
First added on: Sep 17, 2024